Category: Zoll Medical Corp.
InspireMD nets nearly $23 million from a public stock offering, saying it plans to use the proceeds to pursue U.S. approval of its MGuard coronary and carotid stents.
InspireMD (OTC:NSPR) said it added some $23 million to its coffers in a public stock offering.
The Tel Aviv-based medical device company makes the MGuard device, designed to protect against embolism after stenting procedures.
Zoll Medical wins a lawsuit and an injunction preventing Germany's ELan Med GmbH from manufacturing or selling products designed to work with Zoll's Intravascular Temperature Management Systems.
Massachusetts medical device maker Zoll Medical touted a legal win against Germany's ELan Med GmbH, landing an injunction that prevents ELan from manufacturing or selling any infringing products.
A judge for the District Court of Munich, Germany, ruled in Zoll's favor that certain of ELan's devices infringe on Zoll's for its Intravascular Temperature Management Systems patents, according to a press release.
Zoll Medical wins 510(k) clearance for its AED Plus CPR-assist technology.
Asahi Kasei (TYO:3407) subsidiary Zoll Medical won 510(k) clearance from the FDA for its fully-automated AED Plus device, which improves on the former semi-automatic model.
The new automated external defibrillator allows emergency responders to pre-program a shock instead of pushing the "shock" button.
Zoll Medical breaks into the Japanese market with its temperature regulating device, the first of its kind to win regulatory approval in the Land of the Rising Sun.
Japan's Ministry of Health, Labour and Welfare granted Shonin approval to Zoll Medical's intravascular temperature managment device for treating patients with high fevers and brain damage.
The Chelmsford, Mass.-based medical device company's temperature regulating device is designed to control high fevers in patients with neurological impairment. It provides direct cooling and warming to the circulatory system via a ballon catheter.
Nine prominent medical device companies sign on to a pledge to increase the interoperability of their products in the interest of patient safety.
Nine medical device companies ranging from industry titans to small-cap movers inked a pledge to make the data generated by their devices available to patients, in a move aimed at ridding the healthcare system of unnecessary deaths by 2020.
Zoll CEO Rick Packer tells MassDevice.com about making the decision to sign the pledge to share data in the interest of patient safety.
Medical device maker Zoll Medical is among the 1st medical device companies to sign on to the patient safety and medical device data pledge proposed by Masimo (NSDQ:MASI) founder & CEO Joe Kiani this weekend.
The pledge includes promises to open up patient data gathered by medical devices to clinicians, patients and anyone else who can help improve patient care.
Zoll CEO Rick Packer says that tax repeal advocates on the front lines of the discussions with Washington are optimistic that the levy on device makers will be addressed before it hits in January.
As the medical device excise tax creeps closer to its planned launch date, all eyes are on Congress to see whether medtech lobbying efforts will yield a win for the industry.
While lawmakers weigh the tax and argue their way toward the so-called fiscal cliff, device industry stakeholders are placing their bets on whether or not the excise tax will survive until January.
